» Articles » PMID: 2833104

Clonal Rearrangement for Immunoglobulin and T-cell Receptor Genes in Systemic Castleman's Disease. Association with Epstein-Barr Virus

Overview
Journal Am J Pathol
Publisher Elsevier
Specialty Pathology
Date 1988 Apr 1
PMID 2833104
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Castleman's disease is a morphologically and clinically heterogeneous lymphoproliferative disorder. Both a localized benign variant and an aggressive form with systemic manifestations have been described. To investigate the differences between these variants of Castleman's disease, the authors analyzed lymph node DNA from 4 patients with the localized type and 4 with the systemic type of Castleman's disease for immunoglobulin and T-cell receptor gene rearrangements. The role of Epstein-Barr virus (EBV) and cytomegalovirus (CMV) was also studied by viral genomic DNA probes. They detected clonal rearrangements in 3 of the 4 patients with the systemic variant of Castleman's; no patients with localized disease had rearrangements. Copies of EBV genome were also detected in 2 of the 3 patients with clonal rearrangements. These results suggest that systemic Castleman's disease is a disorder distinct from the classical localized variant in that it may evolve into a clonal lymphoproliferation.

Citing Articles

A Review of Genetic Abnormalities in Unicentric and Multicentric Castleman Disease.

Butzmann A, Kumar J, Sridhar K, Gollapudi S, Ohgami R Biology (Basel). 2021; 10(4).

PMID: 33804823 PMC: 8063830. DOI: 10.3390/biology10040251.


Clinical Analysis of Castleman's Disease of the Lacrimal Gland.

Li D, Tang D, Sun F J Ophthalmol. 2021; 2020:3718305.

PMID: 33489328 PMC: 7803145. DOI: 10.1155/2020/3718305.


Lymphotropic herpes virus (EBV, HHV-6, HHV-8) DNA sequences in HIV negative Castleman's disease.

Barozzi P, Luppi M, Masini L, Marasca R, Savarino M, Morselli M Clin Mol Pathol. 1996; 49(4):M232-5.

PMID: 16696081 PMC: 408065. DOI: 10.1136/mp.49.4.m232.


Cellular localisation of HHV-8 in Castleman's disease: is there a link with lymph node vascularity?.

OLeary J, Kennedy M, Howells D, Silva I, Uhlmann V, Luttich K Mol Pathol. 2000; 53(2):69-76.

PMID: 10889905 PMC: 1186908. DOI: 10.1136/mp.53.2.69.


Genetic changes in atypical hyperplasia and lymphoma with angioimmunoblastic lymphadenopathy and dysproteinaemia in the same patients.

Ohshima K, Kikuchi M, Hashimoto M, Kozuru M, Uike N, Kobari S Virchows Arch. 1994; 425(1):25-32.

PMID: 7921409 DOI: 10.1007/BF00193945.


References
1.
Ho M, Miller G, ATCHISON R, BREINIG M, Dummer J, Andiman W . Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infection. J Infect Dis. 1985; 152(5):876-86. PMC: 3154749. DOI: 10.1093/infdis/152.5.876. View

2.
Artusi T, Bonacorsi G, Saragoni A, Spedicato M, Rinaldi G, Federico M . Castleman's lymphoadenopathy: twenty years of observation. II. Generalized form. Haematologica. 1982; 67(1):124-42. View

3.
Birx D, Redfield R, Tosato G . Defective regulation of Epstein-Barr virus infection in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related disorders. N Engl J Med. 1986; 314(14):874-9. DOI: 10.1056/NEJM198604033141403. View

4.
Hsu S, RAINE L, FANGER H . Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem. 1981; 29(4):577-80. DOI: 10.1177/29.4.6166661. View

5.
Frizzera G, Peterson B, BAYRD E, Goldman A . A systemic lymphoproliferative disorder with morphologic features of Castleman's disease: clinical findings and clinicopathologic correlations in 15 patients. J Clin Oncol. 1985; 3(9):1202-16. DOI: 10.1200/JCO.1985.3.9.1202. View